Author: Aruna Kaim

Fintech lenders have firmly established dominance over India’s retail credit landscape, capturing an unprecedented 77% share of the personal loan market by volume in the fiscal year ended March 31, 2026 (FY26). According to an annual industry report, digital-first non-banking financial companies (NBFCs) and platforms have rapidly outpaced traditional public and private sector banks by leveraging frictionless origination and small-ticket credit deployment. The Volume vs. Value Dichotomy While fintech platforms completely dominate the sheer number of loans disbursed, a deep dive into the credit architecture reveals a highly polarized market structure when measured by total financial value: By Volume (77%…

Alternative asset manager Blackstone has announced the final close of its third Asia-focused private equity vehicle, Blackstone Capital Partners Asia III (BCP Asia III), at a record-breaking $13.1 billion. The fund significantly cleared its initial $10 billion target, hitting its strict hard cap and effectively more than doubling the capital raised by its predecessor vehicle. This massive fundraise establishes the largest regional private equity pool in Blackstone’s history and marks a major milestone at a time when global buyout fundraising has noticeably chilled. Breaking the Global Fundraising Gloom Over the past 24 months, the private equity landscape has struggled with…

The Adani Group has delivered a powerful financial performance for the fiscal year ended March 31, 2026 (FY26), logging its highest-ever operating profit alongside an aggressive capital expenditure (capex) program. The conglomerate’s results underscore a rapid operational expansion across its core infrastructure, green energy, and logistics businesses. EBITDA: Earnings Before Interest, Taxes, Depreciation, and Amortization—a key measure of a company’s core operating profitability. Key Financial Highlights The group’s combined financial health showed robust year-on-year growth, driven primarily by its highly stable, utility-focused infrastructure portfolio: Metric FY26 Achievement Significance Group EBITDA ₹94,834 crore An all-time high, marking a substantial 38.3% growth…

European stocks advanced on Tuesday, shaking off recent caution as an optimistic revenue forecast from chip giant STMicroelectronics injected fresh momentum into the technology sector. The broader market rally helped lift regional indices, though mining and industrial heavyweights capped overall gains. The pan-European STOXX 600 index climbed 0.5% during early trading, tracking solid gains across major country-specific benchmarks: Germany’s DAX advanced 0.6% France’s CAC 40 moved up 0.5% Italy’s FTSE MIB outperformed with a 0.7% gain The Catalyst: Tech Sentiment Gets a Semi-Conductor Boost The undisputed star of the session was STMicroelectronics, whose Milan and Paris-listed shares surged over 6.5%.…

Wall Street’s main indexes slipped at Tuesday’s opening bell, pulling back modestly from a series of fresh all-time highs notched in the previous session. Investor sentiment faced a double whammy of macro anxiety and heavy individual stock adjustments: persistent geopolitical friction in the Middle East kept energy supply lines under watch, while an massive equity call by one of tech’s biggest players slowed down a relentless multi-week broad market rally. At the opening bell: The Dow Jones Industrial Average shed 166.0 points, or 0.33%, dropping to 50,912.84. The S&P 500 edged down 4.6 points, or 0.06%, to 7,595.4. The Nasdaq…

The U.S. Securities and Exchange Commission (SEC) and Elon Musk have submitted a joint defense to a Washington, D.C. federal court, urging the approval of a $1.5 million compromise settlement. The filing serves as a direct response to U.S. District Judge Sparkle Sooknanan, who previously raised “red flags” and refused to “rubber stamp” the agreement. The Regulatory Disconnect: $150M vs. 1% Recoupment The civil lawsuit stems from allegations that Musk waited 11 days too long in early 2022 to disclose that his personal holding in Twitter (now X) had crossed the critical 5% threshold. The SEC originally argued that this…

Shares of Fulcrum Therapeutics plummeted 52% on Tuesday following the company’s decision to completely halt the development of pociredir, its lead oral drug candidate for sickle-cell disease. The sudden cancellation came after the U.S. Food and Drug Administration (FDA) signaled sweeping safety concerns regarding the drug’s mechanism, pushing Fulcrum to aggressively cut costs and open the door to a potential sale or merger. The Catalyst: Systemic Risks and the PRC2 Complex Pociredir was engineered to treat sickle-cell disease—an inherited and debilitating blood disorder—by increasing fetal hemoglobin levels. It targeted a specific sub-unit of the PRC2 protein complex, which naturally suppresses…

Following a broad-based market correction, Dalal Street is transitioning from blanket, widespread bearishness into a highly discerning, stock-specific environment. We are approaching a stage where capital will no longer chase broad sectors; instead, there is significant liquidity waiting on the sidelines ready to move aggressively into individual companies that consistently deliver strong financial performance. The earliest signs of this transition are becoming visible in improving market breadth. Our top weekly selections track businesses showing a distinct upward trajectory in their average quantitative scores. This ranking system is built around five fundamental analytical pillars: earnings performance, operational fundamentals, relative valuation metrics,…

Stock Reports Plus, powered by Refinitiv, conducts comprehensive quantitative analyses on more than 4,000 listed equity shares. Rather than relying on simple price movements, the platform evaluates each company by scoring five essential pillars of investment analysis: earnings performance, fundamental health, relative valuation metrics, risk profiles, and price momentum. m.economictimes.com+ 1 To streamline the decision-making process for market participants, we have filtered this extensive universe to isolate only the elite businesses. By cross-referencing companies that achieved a perfect 10-on-10 score with “Buy” or “Strong Buy” recommendations from the Institutional Brokers’ Estimate System (IBES), we have assembled a high-conviction list. m.economictimes.com…

The Indian equity market has kicked off another week with noticeable cuts, extending a persistent downward trend. At this stage, attempting to guess the immediate direction of benchmark indices like the Nifty or Sensex is a futile exercise. Short-term movements are currently swinging between factors completely detached from business realities and shifting core fundamentals. Recent macroeconomic shifts are directly altering the operational outlook and margins for several critical sectors. For anyone navigating the markets today, it is essential to recognize that headwinds are accumulating faster than expected. Beyond general global triggers, domestic pressures have intensified with predictions pointing toward a…